Profile data is unavailable for this security.
About the company
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
- Revenue in USD (TTM)52.93m
- Net income in USD-63.95m
- Incorporated2002
- Employees188.00
- LocationCodexis Inc200 Penobscot DrREDWOOD CITY 94063-4718United StatesUSA
- Phone+1 (650) 421-8100
- Fax+1 (302) 655-5049
- Websitehttps://www.codexis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 58.42m | 2.49m | 84.29m | 213.00 | 36.42 | 20.21 | 21.19 | 1.44 | 0.1667 | 0.1667 | 4.14 | 0.3003 | 2.11 | -- | 5.31 | 274,291.10 | 8.78 | -4.67 | 33.91 | -11.66 | 50.11 | 47.28 | 4.16 | -2.79 | -- | -- | 0.0327 | -- | 13.54 | 12.13 | 164.61 | -- | -29.41 | -- |
| Actuate Therapeutics Inc | 0.00 | -24.12m | 87.16m | 10.00 | -- | 7.97 | -- | -- | -1.19 | -1.19 | 0.00 | 0.4705 | 0.00 | -- | -- | 0.00 | -150.86 | -- | -282.00 | -- | -- | -- | -- | -- | -- | -- | 0.0357 | -- | -- | -- | -10.27 | -- | -- | -- |
| Pyxis Oncology Inc | 2.82m | -97.09m | 91.53m | 44.00 | -- | 1.33 | -- | 32.46 | -1.58 | -1.58 | 0.0457 | 1.11 | 0.0187 | -- | -- | 64,090.91 | -64.53 | -47.22 | -74.33 | -53.45 | 0.00 | -- | -3,442.77 | -2,233.63 | -- | -- | 0.0006 | -- | -- | -- | -4.80 | -- | -- | -- |
| Codexis Inc | 52.93m | -63.95m | 92.13m | 188.00 | -- | 2.39 | -- | 1.74 | -0.7514 | -0.7514 | 0.6238 | 0.4269 | 0.389 | 5.42 | 4.03 | 281,553.20 | -47.00 | -21.95 | -58.53 | -26.20 | 79.31 | 76.67 | -120.82 | -49.88 | 4.02 | -- | 0.5076 | -- | -15.39 | -2.82 | 14.38 | -- | 2.91 | -- |
| TuHURA Biosciences Inc | 0.00 | -43.77m | 92.30m | 19.00 | -- | 4.72 | -- | -- | -1.60 | -1.60 | 0.00 | 0.3273 | 0.00 | -- | -- | 0.00 | -286.97 | -- | -456.76 | -- | -- | -- | -- | -- | -- | -9.01 | 0.0286 | -- | -- | -- | -- | -- | -- | -- |
| Ibio Inc | 300.00k | -24.74m | 92.92m | 20.00 | -- | 1.43 | -- | 309.74 | -1.26 | -1.26 | 0.0112 | 1.88 | 0.007 | -- | -- | 15,000.00 | -57.47 | -30.90 | -65.55 | -37.76 | -- | -- | -8,245.67 | -2,374.12 | -- | -- | 0.00 | -- | 77.78 | -24.57 | -19.00 | -- | -57.50 | -- |
| Cognition Therapeutics Inc | 0.00 | -27.99m | 93.57m | 25.00 | -- | 2.56 | -- | -- | -0.4816 | -0.4816 | 0.00 | 0.4138 | 0.00 | -- | -- | 0.00 | -78.86 | -59.00 | -108.44 | -75.05 | -- | -- | -- | -- | -- | -3,450.08 | 0.00 | -- | -- | -- | -31.73 | -- | -51.16 | -- |
| Dogwood Therapeutics Inc | 0.00 | -39.98m | 93.89m | 12.00 | -- | -- | -- | -- | -24.92 | -24.92 | 0.00 | 33.75 | 0.00 | -- | -- | 0.00 | -81.05 | -52.48 | -84.58 | -55.93 | -- | -- | -- | -- | -- | -178.51 | 0.00 | -- | -- | -- | -142.90 | -- | -- | -- |
| Kazia Therapeutics Ltd (ADR) | 80.84k | -14.68m | 94.47m | 12.00 | -- | -- | -- | 1,168.68 | -12.31 | -12.31 | 0.0563 | -3.64 | 0.0083 | -- | 0.0571 | -- | -149.76 | -64.49 | -- | -99.77 | -- | -- | -18,159.65 | -573.31 | -- | -- | -- | -- | -95.09 | 11.58 | 22.69 | -- | -- | -- |
| Citius Oncology Inc | 3.94m | -23.64m | 95.34m | -- | -- | 1.57 | -- | 24.17 | -0.3102 | -0.3102 | 0.0511 | 0.6889 | 0.0394 | 0.0426 | -- | -- | -23.58 | -- | -42.08 | -- | 79.99 | -- | -599.28 | -- | 0.3245 | -112.34 | 0.0611 | -- | -- | -- | -17.08 | -- | -- | -- |
| PMV Pharmaceuticals Inc | 0.00 | -82.71m | 95.78m | 63.00 | -- | 0.7883 | -- | -- | -1.58 | -1.58 | 0.00 | 2.28 | 0.00 | -- | -- | 0.00 | -46.29 | -21.46 | -49.90 | -22.32 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 14.87 | -- | 43.14 | -- |
| Biomea Fusion Inc | 0.00 | -95.71m | 96.86m | 42.00 | -- | 5.22 | -- | -- | -2.39 | -2.39 | 0.00 | 0.2625 | 0.00 | -- | -- | 0.00 | -115.59 | -62.24 | -156.30 | -68.84 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -18.06 | -- | -- | -- |
| aTyr Pharma Inc | 190.00k | -75.12m | 97.01m | 56.00 | -- | 1.21 | -- | 510.56 | -0.8345 | -0.8345 | 0.0021 | 0.8188 | 0.0019 | -- | 0.1323 | 3,392.86 | -75.78 | -47.98 | -88.99 | -54.91 | -- | -- | -39,540.53 | -978.90 | -- | -- | 0.0127 | -- | -33.43 | -11.05 | -27.06 | -- | -3.83 | -- |
| Anixa Biosciences Inc | 0.00 | -10.93m | 98.80m | 4.00 | -- | 6.45 | -- | -- | -0.3369 | -0.3369 | 0.00 | 0.4593 | 0.00 | -- | -- | 0.00 | -58.55 | -47.85 | -62.09 | -49.81 | -- | -- | -- | -8,381.30 | -- | -- | 0.00 | -- | -- | -- | 12.96 | -- | -- | -- |
| Precision BioSciences Inc | 698.00k | -83.60m | 99.15m | 67.00 | -- | 3.15 | -- | 142.04 | -8.40 | -8.40 | 0.0695 | 1.38 | 0.0057 | -- | 0.9001 | 6,462.96 | -67.76 | -26.22 | -76.07 | -33.68 | -- | -- | -11,977.36 | -87.80 | -- | -190.84 | 0.5736 | -- | 40.98 | 25.30 | 116.85 | -- | -59.31 | -- |
| Gossamer Bio Inc | 44.05m | -156.16m | 99.20m | 144.00 | -- | -- | -- | 2.25 | -0.6872 | -0.6872 | 0.1939 | -0.356 | 0.1574 | -- | 5.57 | 305,909.70 | -55.80 | -51.30 | -69.95 | -58.28 | -- | -- | -354.50 | -822.21 | -- | -15.04 | 1.71 | -- | -- | -- | 68.56 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to Codexis Inc's reporting currency: US Dollar USD
49.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| abrdn, Inc.as of 31 Dec 2025 | 7.97m | 8.82% |
| Opaleye Management, Inc.as of 31 Dec 2025 | 6.79m | 7.52% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 6.11m | 6.76% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.36m | 4.82% |
| Nantahala Capital Management LLCas of 31 Dec 2025 | 3.99m | 4.42% |
| Telemark Asset Management LLCas of 31 Dec 2025 | 3.85m | 4.26% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2025 | 3.79m | 4.20% |
| Millennium Management LLCas of 31 Dec 2025 | 3.14m | 3.47% |
| Prescott Group Capital Management LLCas of 31 Dec 2025 | 2.57m | 2.84% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.03m | 2.24% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
